GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IntelliPharmaCeutics International Inc (OTCPK:IPCIF) » Definitions » ROIC %

IntelliPharmaCeutics International (IntelliPharmaCeutics International) ROIC % : -197.61% (As of Aug. 2023)


View and export this data going back to 1996. Start your Free Trial

What is IntelliPharmaCeutics International ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. IntelliPharmaCeutics International's annualized return on invested capital (ROIC %) for the quarter that ended in Aug. 2023 was -197.61%.

As of today (2024-04-28), IntelliPharmaCeutics International's WACC % is 10.25%. IntelliPharmaCeutics International's ROIC % is -77.92% (calculated using TTM income statement data). IntelliPharmaCeutics International earns returns that do not match up to its cost of capital. It will destroy value as it grows.


IntelliPharmaCeutics International ROIC % Historical Data

The historical data trend for IntelliPharmaCeutics International's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntelliPharmaCeutics International ROIC % Chart

IntelliPharmaCeutics International Annual Data
Trend Nov13 Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22
ROIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -259.51 -173.52 -115.22 -117.77 -92.47

IntelliPharmaCeutics International Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -49.53 -59.82 -37.48 -4.01 -197.61

Competitive Comparison of IntelliPharmaCeutics International's ROIC %

For the Biotechnology subindustry, IntelliPharmaCeutics International's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IntelliPharmaCeutics International's ROIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IntelliPharmaCeutics International's ROIC % distribution charts can be found below:

* The bar in red indicates where IntelliPharmaCeutics International's ROIC % falls into.



IntelliPharmaCeutics International ROIC % Calculation

IntelliPharmaCeutics International's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Nov. 2022 is calculated as:

ROIC % (A: Nov. 2022 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Nov. 2021 ) + Invested Capital (A: Nov. 2022 ))/ count )
=-2.851 * ( 1 - -0.17% )/( (2.912 + 3.265)/ 2 )
=-2.8558467/3.0885
=-92.47 %

where

IntelliPharmaCeutics International's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Aug. 2023 is calculated as:

ROIC % (Q: Aug. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: May. 2023 ) + Invested Capital (Q: Aug. 2023 ))/ count )
=-6.952 * ( 1 - 0% )/( (3.026 + 4.01)/ 2 )
=-6.952/3.518
=-197.61 %

where

Note: The Operating Income data used here is four times the quarterly (Aug. 2023) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IntelliPharmaCeutics International  (OTCPK:IPCIF) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, IntelliPharmaCeutics International's WACC % is 10.25%. IntelliPharmaCeutics International's ROIC % is -77.92% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


IntelliPharmaCeutics International ROIC % Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


IntelliPharmaCeutics International (IntelliPharmaCeutics International) Business Description

Traded in Other Exchanges
Address
30 Worcester Road, Toronto, ON, CAN, M9W 5X2
IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.